Simultaneous Progress of Vaccine Production and Clinical Trials

[Asia Economy Reporter Naju-seok] Russia announced on the 15th (local time) that the first batch of the world's first novel coronavirus (COVID-19) vaccine has been produced.

Novel coronavirus disease (COVID-19) vaccine approved by the Russian government <br>[Image source=Yonhap News]

Novel coronavirus disease (COVID-19) vaccine approved by the Russian government
[Image source=Yonhap News]

View original image


The Russian Ministry of Health stated on the same day, without disclosing the exact quantity, that "the first batch of the COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology has been produced." This vaccine was named after "Sputnik V," taking its name from the artificial satellite launched by the Soviet Union, the first in human history.


Russia claims that this vaccine is safe, but the international community and medical circles have raised doubts. The vaccine has not undergone Phase 3 clinical trials, the final stage of testing, and it is known that Phase 1 and 2 trials were conducted on only 38 people.



Russia announced plans to conduct Phase 3 trials in its own country as well as in the United Arab Emirates (UAE), Saudi Arabia, Brazil, and Mexico, while simultaneously producing and supplying the vaccine.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing